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Letter to the Editor
Sir,
EMERGENCY FIBRINOLYTIC TREATMENT OF ACUTE 
MYOCARDIAL INFARCTION
It is generally accepted that the sooner fibrinolytic treatment is started after coronary artery 
occlusion, the better are the chances of preventing myocardial infarction or of reducing the 
extent of myocardial necrosis. Braunwald 1  has suggested that early thrombolytic therapy 
started in the ambulance or in the patient's home can limit the extent of myocardial necrosis 
and his wiew has been supported by several Hungarian cardiologists2-3-4-5-6-7-8-9. 
    After a preliminary report10  we have now attempted to assess the significance of fibrino-
lytic treatment in emergency care by documenting the clinical courses of four patients.
     The courses of the four patients have been monitored since the second half of 1985. All 
were treated on the spot by the staff of a mobile intensive care unit (MICU) of the Hunga-
rian Emergency and Ambulance Service before transfer to hospital for further management
in the intensive therapy unit and the medical ward.
      The following were recorded:
      - time from the onset of pain to the arrival of the MICU and the initiation of fibrinolysis
      - signs indicative of restored myocardial perfusion (reduction of pain, ST elevation and 
         arrhythmia)
       - serum ensyme levels
       - the subsequent clinical course.
       The findings are shown in Table 1.
       All four patients had arrhythmias during treatment by the MICU team and upon arrival at the
hospital. In three patients the arrhythmias occured between the resolution of pain and the return of
the ST segment elevation to normality.
       All the patients had an early, high peak concentration of creatinine phosphokinase. There was
evidence of reocclusion in all patients, on day four in two patients, on day nine in the third and after
eight months in the fourth. One patient died suddenly at home after six months.
       It may be asked why so few patients are given pre-hospital fibrinolytic treatment. A partial an-
swear is that only recently that the Hungarian Emergency and Ambulance Service has issued guide-
lines for the use of pre-hospital fibrinolytic therapy by emergency care specialists. Previously this
treatment has been used only by intensivists in the MICU with support from the medical ward of the
Hospital of Hungarian Emergency and Ambulance Service. Another reason for the limited use is the
need to make an unequivocal diagnosis of myocardial infarctionon the spot and to exclude all cont-
raindications.
        In our health system the doctors of the Ambulance Service have the most opportunities for 
using fibrinolytic treatment in the earliest stages of acute myocardial infarction.
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Dr R M Donaldson replies...
We are grateful for your comments.
    As expressed in our editorial the maximum benefit from thrombolysis occurs in the patient who 
is seen within the first three hours of symptoms, who is undergoing a first infarction , whose infarct 
is anterior, potentially large, and who hasleft ventricular dysfunction. The early administration of 
therapy is essential, as mentioned in your letter. The human element is crucial as is a system for 
transporting the patient. The staff involved must be prepared and it is best to have a therapeutic 
protocol.
     With the exception of the patient in cardiogen shock, immediate angioplasty appears to confer no
benefit and may, in fact, lead to early reocclusion, possibly owing to exacerbation of the preexisting
coronary artery damage. The percentage of patients who are potential candidates for thrombolysis 
has been reported to be as high as 35%, although some studies suggest that it is as low as 10% . We
cannot comment further on the arrhythmias which can occur on reperfusion, although these have 
been well documented in the literature. 
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